Active, not recruiting
Phase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma
NCT02253316
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- City of Hope Duarte, California, United States
- University of California, San Francisco San Francisco, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Emory University - Winship Cancer Institute Atlanta, Georgia, United States